首页> 外国专利> Treatment of Psychiatric Patients with reduced hepatic function with paliperidone

Treatment of Psychiatric Patients with reduced hepatic function with paliperidone

机译:帕潘立酮治疗精神功能不全的精神病患者

摘要

The invention provides a method for treating the psychotic patients with liver failure or possible failure, which comprises the treatment of an effective amount of paliprina and an acid additive acceptable for drugs, The shape of the dwarf and the relationship with the patient, the need for the psychopath. A method for the treatment of psychotic patients with or likely to have liver disease, including an effective amount of paliprina and its pharmaceutically acceptable additive acid,The shape of the dwarf and the relationship with the patient, the need for the psychopath. 1. Method meeting the requirements of item 1, which is characterized by the need for psychiatric treatment for the mentally ill. Another feature of a method that meets the requirements of item 2 is the need for schizophrenia to be treated. Another feature of a method that meets the requirements of item 2 is the need to treat bipolar disorder in patients with mental illness. A. Method of claim 1It is further explained that the patients with psychosis need to treat a specific psychosis composed of slight mental retardation (317 people),Mild mental retardation (318.0)Severe mental retardation (318.1)Severe mental retardation (318.2) mental retardation of unknown severity (319),Autistic (299.0) Rett disorder (299.80),Childhood schizophrenia (299.10)Asperger disorder (29980),Widespread disruption of development not otherwise specified (29980)Comprehensive attention deficit / hyperactivity disorder (314.01)2. attention deficit disorder / hyperactivity disorder (314),2. Hyperactivity impulsive attention deficit / hyperactivity disorder (314.01),Attention deficit / hyperactivity disorder (314.9)Behavioral disorders (type 312.8 in early childhood and adolescence),3. Resistance to obstacles (31381 people)Disturbance behavior disorder not otherwise described (312.9)Lone Ranger (312.00)Behavioral disorder, undifferentiated type (31290)Tourette's disease (307.23)Chronic motor or vowel disorders (307.22)Instantaneous ICT disruption (307.21)ICT disruption...
机译:本发明提供了一种治疗精神病性肝衰竭或可能衰竭的患者的方法,该方法包括治疗有效量的paliprina和药物可接受的酸添加剂,侏儒的形状以及与患者的关系,对精神病患者。一种用于治疗患有或可能患有肝病的精神病患者的方法,包括有效量的帕利普利纳及其药学上可接受的添加剂酸,矮人的形状以及与患者的关系以及对精神病患者的需求。 1.符合第1项要求的方法,其特征在于需要对精神病患者进行精神治疗。满足第2项要求的方法的另一个特征是需要治疗精神分裂症。满足第2项要求的方法的另一个特点是需要治疗精神疾病患者的躁郁症。 A.根据权利要求1所述的方法,其进一步解释为,精神病患者需要治疗由轻度智力低下(317人),轻度智力低下(318.0),重度智力低下(318.1),重度智力低下(318.2),智力低下组成的特定精神病。严重程度未知(319),自闭症(299.0)瑞特障碍(299.80),儿童精神分裂症(299.10)阿斯伯格障碍(29980),未广泛定义的广泛性发育障碍(29980)综合注意力不足/多动症(314.01)2。注意缺陷症/多动症(314),2。多动性冲动注意缺陷/多动障碍(314.01),注意缺陷/多动障碍(314.9)行为障碍(儿童早期和青春期为312.8),3。对障碍的抵抗力(31381人)未另作说明的骚扰行为障碍(312.9)独行侠(312.00)未分化的行为障碍(31290)图雷特病(307.23)慢性运动或元音障碍(307.22)即时ICT中断(307.21)ICT中断...

著录项

  • 公开/公告号CO6080090A1

    专利类型

  • 公开/公告日2009-09-30

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTCA N.V.;

    申请/专利号CO20070099050

  • 发明设计人 BOOM SANDRA;ERDEKENS MARIELLE HENRIETTE;

    申请日2007-09-24

  • 分类号A61K31/423;A61K31/529;A61P25/18;

  • 国家 CO

  • 入库时间 2022-08-21 19:28:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号